Onyx Pharmaceuticals (Nasdaq: ONXX) is a biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
Recent Mentions on Fool.com
- Will ASCO Unlock Big Value in This Cancer Drug Class?
- 3 Earnings Reports That Caught My Attention Last Week
- Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
- Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players
- Fighting Cancer: Colorectal Cancer's Most Promising Treatments